SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-002405
Filing Date
2022-01-10
Accepted
2022-01-10 06:02:36
Documents
53
Period of Report
2022-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm221860d1_8k.htm   iXBRL 8-K 26307
2 EXHIBIT 99.1 tm221860d1_ex99-1.htm EX-99.1 39262
3 EXHIBIT 99.2 tm221860d1_ex99-2.htm EX-99.2 28085
7 GRAPHIC tm221860d1_ex99-1img001.jpg GRAPHIC 210093
8 GRAPHIC tm221860d1_ex99-1img002.jpg GRAPHIC 276053
9 GRAPHIC tm221860d1_ex99-1img003.jpg GRAPHIC 277563
10 GRAPHIC tm221860d1_ex99-1img004.jpg GRAPHIC 201791
11 GRAPHIC tm221860d1_ex99-1img005.jpg GRAPHIC 230205
12 GRAPHIC tm221860d1_ex99-1img006.jpg GRAPHIC 168752
13 GRAPHIC tm221860d1_ex99-1img007.jpg GRAPHIC 136109
14 GRAPHIC tm221860d1_ex99-1img008.jpg GRAPHIC 167536
15 GRAPHIC tm221860d1_ex99-1img009.jpg GRAPHIC 103897
16 GRAPHIC tm221860d1_ex99-1img010.jpg GRAPHIC 195102
17 GRAPHIC tm221860d1_ex99-1img011.jpg GRAPHIC 173059
18 GRAPHIC tm221860d1_ex99-1img012.jpg GRAPHIC 150664
19 GRAPHIC tm221860d1_ex99-1img013.jpg GRAPHIC 190720
20 GRAPHIC tm221860d1_ex99-1img014.jpg GRAPHIC 94546
21 GRAPHIC tm221860d1_ex99-1img015.jpg GRAPHIC 147483
22 GRAPHIC tm221860d1_ex99-1img016.jpg GRAPHIC 133075
23 GRAPHIC tm221860d1_ex99-1img017.jpg GRAPHIC 146193
24 GRAPHIC tm221860d1_ex99-1img018.jpg GRAPHIC 209996
25 GRAPHIC tm221860d1_ex99-1img019.jpg GRAPHIC 163824
26 GRAPHIC tm221860d1_ex99-1img020.jpg GRAPHIC 148950
27 GRAPHIC tm221860d1_ex99-1img021.jpg GRAPHIC 168034
28 GRAPHIC tm221860d1_ex99-1img022.jpg GRAPHIC 78777
29 GRAPHIC tm221860d1_ex99-1img023.jpg GRAPHIC 220148
30 GRAPHIC tm221860d1_ex99-1img024.jpg GRAPHIC 98770
31 GRAPHIC tm221860d1_ex99-2img001.jpg GRAPHIC 209543
32 GRAPHIC tm221860d1_ex99-2img002.jpg GRAPHIC 276053
33 GRAPHIC tm221860d1_ex99-2img003.jpg GRAPHIC 199218
34 GRAPHIC tm221860d1_ex99-2img004.jpg GRAPHIC 187217
35 GRAPHIC tm221860d1_ex99-2img005.jpg GRAPHIC 227827
36 GRAPHIC tm221860d1_ex99-2img006.jpg GRAPHIC 183460
37 GRAPHIC tm221860d1_ex99-2img007.jpg GRAPHIC 156570
38 GRAPHIC tm221860d1_ex99-2img008.jpg GRAPHIC 230983
39 GRAPHIC tm221860d1_ex99-2img009.jpg GRAPHIC 203901
40 GRAPHIC tm221860d1_ex99-2img010.jpg GRAPHIC 167356
41 GRAPHIC tm221860d1_ex99-2img011.jpg GRAPHIC 160841
42 GRAPHIC tm221860d1_ex99-2img012.jpg GRAPHIC 188450
43 GRAPHIC tm221860d1_ex99-2img013.jpg GRAPHIC 222377
44 GRAPHIC tm221860d1_ex99-2img014.jpg GRAPHIC 98733
45 GRAPHIC tm221860d1_ex99-2img015.jpg GRAPHIC 220130
  Complete submission text file 0001104659-22-002405.txt   9975729

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20220110.xsd EX-101.SCH 3195
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20220110_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20220110_pre.xml EX-101.PRE 22717
47 EXTRACTED XBRL INSTANCE DOCUMENT tm221860d1_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 22519522
SIC: 2834 Pharmaceutical Preparations